Inactive

GenScript Custom Monoclonal Antibodies This contract action is for supplies that the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 1... GenScript Custom Monoclonal Antibodies This contract action is for supplies that the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. CEMB utilizes GenScript Custom Monoclonal Antibodies within our laboratory. The supply of Custom Monoclonal antibodies is paramount to our lab work. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. The NAICS 541714 and the PSC AJ13 are the classifications for this biological procurement. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Gary Morgan, Contract Specialist at gmorgan1@cdc.gov by 5:00PM EST Monday, July 29, 2024.